AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

Chronic diseases like diabetes, heart disease ... enhances treatment accuracy and alleviates the stress associated with ...

"The best medication for Parkinson's will come from Israel. It will be a hybrid medication ... Integrative medicine, which is something we don't understand, is very, very important in treating any ...

Alternatives to L-dopa for initial treatment of Parkinson's disease (PD) should be considered for patients younger than 65-70 years. Nonmotor symptoms are very common in PD and include ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

Objective To investigate the effect on survival of treatment with memantine in patients with dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD). Methods 75 patients with DLB ...